We are preparing the requested document. Please wait, this may take a while...!
|Antigen||Suppressor of Cytokine Signaling 4 (SOCS4) Antibodies|
|Conjugate||This SOCS4 antibody is un-conjugated Alternatives|
Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunoprecipitation (IP), Western Blotting (WB)
|Supplier||Log in to see|
Product Details anti-SOCS4 AntibodyTarget Details SOCS4 Application Details Handling Images
|Specificity||Peptide from the C-terminus of human SOCS4|
Synthetic peptide from human SOCS4.
Type of Immunogen: Synthetic peptide
Target Details SOCS4Product Details anti-SOCS4 Antibody Application Details Handling Images back to top
|Alternative Name||SOCS4 (SOCS4 Antibody Abstract)|
Name/Gene ID: SOCS4
Synonyms: SOCS4, CIS4, SOCS-4, SSI4, SOCS-7
|Pathways||JAK-STAT Signaling, EGFR Signaling Pathway|
Application DetailsProduct Details anti-SOCS4 Antibody Target Details SOCS4 Handling Images back to top
Approved: IHC-P (10 μg/mL), IP (0.3 - 0.5 μg/10 x106), WB (0.5 - 2 μg/mL)
Usage: Immunohistochemistry: This antibody was validated for use in immunohistochemistry on a panel of 21 formalin-fixed, paraffin-embedded (FFPE) human tissues after heat induced antigen retrieval in pH 6.0 citrate buffer. After incubation with the primary antibody, slides were incubated with biotinylated secondary antibody, followed by alkaline phosphatase-streptavidin and chromogen. The stained slides were evaluated by a pathologist to confirm staining specificity. The optimal working concentration for this antibody was determined to be 10 μg/mL.
|Restrictions||For Research Use only|
HandlingProduct Details anti-SOCS4 Antibody Target Details SOCS4 Application Details Images back to top
|Buffer||PBS, pH 7.4, 0.05 % sodium azide.|
|Precaution of Use||This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.|
|Handling Advice||avoid freezing|
|Storage Comment||+4°C, avoid freezing|
ImagesProduct Details anti-SOCS4 Antibody Target Details SOCS4 Application Details Handling back to top